SL4903 CAR-T Therapy for Relapsed/Refractory Multiple Myeloma
Clinical trial NCT07234721 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07234721
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- NOT_YET_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-01
- Primary completion
- 2028-03-20
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.